Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
First molecular record of Panaeolus subbalteatus (Psathyrellaceae, Agaricales) from Pakistan.Unknown journal · 2026-07-08Psilocybin therapy for adult females with anorexia nervosa: pilot study.The British Journal of Psychiatry · 2026-07-07α2-Adrenergic receptor modulates 5-HT2A-mediated behavioral effects of MDMA and psilocybin in mice.Molecular Psychiatry · 2026-07-06CSF galanin and noradrenaline downregulation by psilocybin therapy in major depressive disorder.Neuropsychopharmacology · 2026-07-06The need for another tool: Australian healthcare professionals on the use of psilocybin for existential distress in people with cancer.BMC Medicine · 2026-07-05Unmixing the psychedelic connectome: Brain network traits of psilocybinNetwork Neuroscience · 2026-07-01Investigating the impact of serotonergic psychedelic drugs, MDMA and ketamine on social cognition in psychiatric disorders: A scoping review.Unknown journal · 2026-06-30Revealing shortcomings in the assessment of psilocybin effects on OCD-related symptoms in preclinical and clinical studies: A systematic reviewJournal of Affective Disorders Reports · 2026-06-30Blinding Integrity in Psychedelic Randomized Clinical Trials: A Systematic Review.Unknown journal · 2026-06-30Implementing psilocybin-assisted therapy in palliative care settings: A survey of stakeholders.Palliative medicine · 2026-06-30Study Protocol for "Exploring the safety and therapeutic potential of psilocybin in the treatment of anorexia nervosa in adolescents and young adults".PLoS ONE · 2026-06-29Psilocybin reduces fear memory and restores neuroplasticity in the hippocampus and medial prefrontal cortex.Journal of Psychopharmacology · 2026-06-27DESI-MSI-Based Multi-Organ Distribution Mapping of Psilocin in ZebrafishMolecules · 2026-06-17Community engagement as a foundation for implementation research for group psilocybin assisted therapy in New MexicoFrontiers in Public Health · 2026-06-16Psychedelics disrupt hierarchical cortical propagations in the default mode network of humans and miceProceedings of the National Academy of Sciences · 2026-06-07Correction to: Preliminary Evidence of Sleep Improvements Following Psilocybin Administration, and their Involvement in Antidepressant Therapeutic ActionCurrent Psychiatry Reports · 2026-06-04Prenatal stress, excitatory-inhibitory imbalance, and ADHD risk: a hypothesis-driven perspective on psilocybin-induced neuroplasticityTranslational Psychiatry · 2026-06-04Current status and future prospects of research on psilocybin's regulation of neurotransmitters and their receptors related to the pathogenesis of tinnitusHearing Research · 2026-06-03Bringing Psilocybin-Assisted Therapy to Palliative Oncology: Early Lessons from Real-World ImplementationHealthcare · 2026-06-02From Altered States to Altered Trajectories and From Molecules to Meaning: A Network Meta Analysis Mapping Comparative Efficacy of Psychedelic Assisted Therapies in Modern PsychiatryBJPsych Open · 2026-05-31Patient perceptions towards psychedelics for musculoskeletal pain: A cross-sectional surveymedRxiv · 2026-05-31EE127 A REVIEW OF HEALTH ECONOMIC ANALYSES OF PSILOCYBIN, MIDOMAFETAMINE(MDMA), AND KETAMINE-BASED TREATMENTS FOR MENTAL HEALTH CAREValue in Health · 2026-05-31Psilocybin restores behavior and 5-HT2A signaling while reducing microglial density after chronic traumatic brain injury in ratsCell Reports Medicine · 2026-05-31Effects of psilocybin on sleep quality and brain microstructure in chronic cluster headacheJournal of Psychopharmacology · 2026-05-28Overcoming Pharmacokinetic and Peripheral Safety Challenges in Psychedelic Therapies: The Promise of Advanced Drug Delivery Systems.Unknown journal · 2026-05-24PsiConnect: Multimodal Neuroimaging of Context-Dependent Brain and Behaviour Dynamics under PsilocybinScientific Data · 2026-05-20Short-Term and Late-Term Effects of Psilocybin on Symptoms in Major DepressionJAMA Network Open · 2026-05-14Psilocybin-Assisted Therapy for Adolescent Anorexia Nervosa: Clinical Considerations and Emerging Models of CareCurrent Psychiatry Reports · 2026-05-13Rapid-acting interventions in treatment-resistant depression - a comparative review of esketamine and psilocybinJournal of Pre-Clinical and Clinical Research · 2026-05-11Trials, trips, and tribulations: pathways for implementing psychedelic therapy in IrelandThe International Journal of Neuropsychopharmacology · 2026-05-08Neural correlates of insight on psilocybin: a within-subjects, healthy volunteer studyUnknown journal · 2026-05-07Effects of psychedelic use on authoritarian attitudes revisitedJournal of Psychopharmacology · 2026-04-30Integrating the Mystical Experience Questionnaire Into a Broader Psychometric Framework: English Validation of the Psychedelic Experience Scale and Comparison of Psilocybin and LSD Sessions Across Two Controlled SettingsRepository for Publications and Research Data (ETH Zurich) · 2026-04-29Evaluating the evidence for repressed memory recovery in psychedelic contextsPsychopharmacology · 2026-04-28“Large-Scale and Local Functional Connectivity Changes Following Psilocybin Administration in Methamphetamine Use DisorderAmerican Journal of Neuroradiology · 2026-04-23Case Report: Repeated low doses of psilocybin reduce perceived symptom severity but fail to restore cognitive flexibility in a case of severe obsessive-compulsive disorder: an observational case study of identical twinsFrontiers in Psychiatry · 2026-04-20Psychedelics: Historical Context, Emerging Science, and Future Clinical FrontiersJournal of Mental Health Disorders · 2026-04-17Psychedelics and Autism Therapy: A Review of Current Research and Future DirectionsCurrent Issues in Molecular Biology · 2026-04-17Psilocybin for Treatment of Prolonged Grief Disorder: An Open-Label Feasibility Study ProtocolPsychoactives · 2026-04-12Observing the mind under psychedelics: conceptual metaphors used following four once-weekly macrodoses of psilocybinPhilosophical Psychology · 2026-04-09Additional file 1 of Evaluation of a facilitator training program in a randomized controlled trial of psilocybin treatment for depressionFigshare · 2026-04-08Severe Illness Associated with Eating Mushroom-Containing Chocolate Products - United States, January-October 2024.MMWR. Morbidity and mortality weekly report · 2026-04-08Brain-MGF: Multimodal Graph Fusion Network for EEG-FMRI Brain Connectivity Analysis Under PsilocybinUnknown journal · 2026-04-07Evaluation of a facilitator training program in a randomized controlled trial of psilocybin treatment for depressionBMC Medical Education · 2026-04-07Clinical Characteristics of Emergency Visits Related to Recreational Psychedelic UseCommunity Mental Health Journal · 2026-03-31An international mega-analysis of psychedelic drug effects on brain circuit functionNature Medicine · 2026-03-31The astrocytes in the prefrontal cortex contribute to the rapid antidepressant-like effects of psilocybin in the chronic restraint stress mouse modelProgress in Neuro-Psychopharmacology and Biological Psychiatry · 2026-03-31Mystical dynamics: renewal, luminous light, and ego disintegration as key features associated with mystical oneness-a psychometric analysis using the PES100 in controlled psychedelic studiesReligion Brain & Behavior · 2026-03-30Mapping cognitive-behavioral approach in psychedelic-assisted treatment: a systematic review across phases with classic and non-classic psychedelicsEuropean Archives of Psychiatry and Clinical Neuroscience · 2026-03-2726-CCC-15854-ACC TALK ABOUT A BAD TRIP!: PSILOCYBIN USE WITH PRE-EXISTING CARDIOVASCULAR DISEASE, A CASE REPORTJournal of the American College of Cardiology · 2026-03-26Raman Activity Investigation and Utilization of PsilocybinJournal of Raman Spectroscopy · 2026-03-18Psychedelics for treatment of negative symptoms and depressive symptoms in schizophrenia spectrum disorder: A narrative reviewSchizophrenia Research · 2026-03-12Strategic Neurodelivery of Psychedelic Compounds: Bridging MolecularPharmacology with Therapeutic Innovation in CNS DisordersCNS & Neurological Disorders - Drug Targets · 2026-03-10Age moderates the relationship between psychedelics use and mental health in naturalistic settingsResearch Square · 2026-03-09Impact of formulation variables on the quality attributes of psilocybin-loaded oral thin films for early-phase developmentJournal of Drug Delivery Science and Technology · 2026-03-09Psilocybin microdosing in the United States: Insights from a nationally representative surveyAddiction · 2026-03-07Synthesis and Characterization of Psilocybin Metabolites and Deuterated AnalogsACS Chemical Neuroscience · 2026-03-02Journeying into Right Relations: Scientists Turn to Psilocybin to Shift Psychological Burdens of Global Environmental Change and Find Transformational Pathways ForwardAction Research · 2026-02-28Meaning and Psychedelics in Palliative Care: A Narrative Review.Journal of pain and symptom management · 2026-02-28Psychedelics and the Extracellular Matrix: Rewiring Neuroplasticity and Metaplasticity for Next-Generation Psychiatric Therapies.Unknown journal · 2026-02-27Sense-Making Around Psilocybin in UK Women Experiencing Cancer-Related Existential Distress: An Interpretative Phenomenological AnalysisQualitative Health Research · 2026-02-16Rebuttal to “Questioning the recovery of dissociated traumatic memories under psilocybin”Journal of Eating Disorders · 2026-02-16Network pharmacology and molecular simulation reveal the entourage effect mechanisms of psilocybin-producing mushrooms on the brainScientific Reports · 2026-02-13Trip sitting or just sitting? Session facilitators substantially influence psychedelic experiences in clinical trials but not in healthy onesPsychiatry Research · 2026-02-12Cardiac Consequences Associated with Psychedelic Use: A Systematic Review of Lysergic Acid Diethylamide, 3,4-Methylenedioxymethamphetamine, and 5-Hydroxytryptamine 2B-Mediated Valvular Heart DiseasePharmacopsychiatry · 2026-02-04Spatiotemporal mapping of brain organisation following the administration of 2C-B and psilocybinMolecular Psychiatry · 2026-02-02Self-medication with psychedelics: a scoping review and narrative synthesis of review-level evidenceExploratory Research in Clinical and Social Pharmacy · 2026-01-25Consistency of protocol and safety data reporting in clinical trial registrations and corresponding publications of interventions involving MDMA and psilocybinJournal of Clinical Epidemiology · 2026-01-22Low, non-psychedelic doses of psilocybin as a novel treatment for MASLD, obesity and type 2 diabetes via 5-HT2B receptor-dependent mechanismsRepository for Publications and Research Data (ETH Zurich) · 2026-01-19Sense-making around psilocybin in UK women experiencing cancer-related existential distress: An Interpretative Phenomenological AnalysisResearch Explorer (The University of Manchester) · 2026-01-08Motivation-based subtypes of psilocybin microdosersOpen Collections · 2025-12-31COMBINATION OF PSILOCYBIN AND COGNITIVE BEHAVIORAL THERAPY IMPROVES OXYTOCIN LEVELS AND DEPRESSIVE SYMPTOMS IN PATIENTS WITH MAJOR DEPRESSIVE DISORDERGenetics and Molecular Research · 2025-12-31Facing Mortality Together: A Constructivist Grounded Theory Analysis of Group Psilocybin Therapy Among Older Long-Term AIDS Survivor Gay MenPalliative Medicine Reports · 2025-12-31Effects of Serotonergic Psychedelics on Synaptic Function and NeuroplasticityOPUS FAU - Online publication system of Friedrich-Alexander-Universität Erlangen-Nürnberg · 2025-12-31An exploration of the relationships between the effects of psilocybin on behavior, 5-HT2A receptor occupancy, and neuroplastic effects in miceJournal of Psychopharmacology · 2025-12-31Single-dose psilocybin promotes cell-type-specific changes of neurons in the orbitofrontal cortexNeurotherapeutics · 2025-12-31Psilocybin Production With Genetically Modified Aspergillus nidulans Under Pressurized ConditionsBiotechnology and Bioengineering · 2025-12-29A qualitative analysis of participant expectations and experiences of psilocybin-assisted psychotherapy for methamphetamine use disorderAddiction · 2025-12-21Magic mushrooms and mood: exploring Psilocybin as a depression treatmentJournal of the Pakistan Medical Association · 2025-12-19Wherefore the magic? The evolutionary role of psilocybin in naturebioRxiv · 2025-12-18Breaking the chains of depression: A systematic review and meta-analysis of psilocybin therapyJournal of Affective Disorders · 2025-12-16Preadministration of Lorazepam Negates the Long-Term Antidepressant-Like Effects of Psilocybin in Male Wistar Kyoto RatsPsychedelic Medicine · 2025-12-15Exploring Determinants of Psilocybin Acceptance as an Alternative Modality for Major Depressive Disorder: A Pilot StudyJournal of Complementary and Alternative Medical Research · 2025-12-15Stepping back into life: How Psychedelic Assisted Psychotherapy transforms the way of life of the terminally illGeneral Hospital Psychiatry · 2025-12-09Unlocking the power of tryptamine alkaloids in Psilocybe fungi: chemistry, mental health potential and legal challengesMycological Progress · 2025-12-07Disengaged: A systematic review of community engagement in psychedelic-assisted therapy research.Unknown journal · 2025-12-06Unexpected Detection of Psilocybin in a 100 mg Tramadol Tablet: A Forensic Case ReportDOAJ (DOAJ: Directory of Open Access Journals) · 2025-11-30Psychedelics for the Treatment of Substance Use DisordersSUCHT - Zeitschrift für Wissenschaft und Praxis / Journal of Addiction Research and Practice · 2025-11-30Psilocybin Maintains Better Brain Function in an Alzheimer’s Disease Model with Reduced Neuroinflammation and Improved Hippocampal NeurogenesisUnknown journal · 2025-11-30Acute Blockade of the Serotonin Transporter With Low Doses of Escitalopram Does Not Alter the Behavioural Responses to Acute PsilocybinEuropean Journal of Neuroscience · 2025-11-30Self-reported improvement in depression, anxiety, and substance use in Spanish-speakers after a memorable psychedelic experiencePsychedelics · 2025-11-19Sex-specific role of the 5-HT2A receptor in psilocybin-induced extinction of opioid rewardNature Communications · 2025-11-19Pharmacotherapy to Prevent Alcohol Relapse in Alcohol-Associated Liver Disease.Unknown journal · 2025-11-18Qualitative insights into psilocybin and LSD experiences: Enhanced connection and emotion processing reported by Spanish-speaking survey respondentsPsychedelics · 2025-11-14Psychedelics produce enduring behavioral effects and functional plasticity through mechanisms independent of structural plasticityNeuropsychopharmacology · 2025-11-11The Psychedelic Psilocin Suppresses Activity of Central Amygdala Corticotropin-Releasing Factor Receptor 1 Neurons and Decreases Ethanol Drinking in Female MiceJournal of Neuroscience · 2025-11-09Psilocybin reduces depressive-like behavior and improves cognition in healthy aging mice via epigenetic regulation of plasticity- and immune-related genesResearch Square · 2025-11-04Psilocybin mitigates chronic behavioral and neurobiological alterations in a rat model of recurrent intimate partner violence-related brain injuryMolecular Psychiatry · 2025-11-04Hormonal Influences on Psilocybin Responsivity Across the Female Lifespan: Toward Personalized Psychedelic-Assisted TherapyPsychoactives · 2025-11-01Ketamine and psilocybin for athletes: A therapeutic breakthrough or a slippery slope?Performance Enhancement & Health · 2025-10-31Psilocybin's effects on obsessive-compulsive behaviors: A systematic review of preclinical and clinical evidencePsychedelics. · 2025-10-27Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) therapy for patients with advanced cancer: protocol for a multi-method feasibility trialPilot and Feasibility Studies · 2025-10-27A novel psychedelic 5-HT2A receptor agonist GM-2505: The pharmacokinetic, safety, and pharmacodynamic profile from a randomized trial healthy volunteerJournal of Psychopharmacology · 2025-10-15Structure-GuidedDesign of Novel 5-HT2A Partial Agonists as PsychedelicAnalogues with Antidepressant EffectsFigshare · 2025-10-14Structure-Guided Design of Novel 5-HT2A Partial Agonists as Psychedelic Analogues with Antidepressant EffectsJournal of Medicinal Chemistry · 2025-10-13Psilocybin’s effect on human brain synaptic plasticityResearch Square · 2025-10-09Neurobiological and Therapeutic Potential of Psilocybin in Psychiatric DisordersJournal of Pharma Insights and Research. · 2025-10-04Understanding psilocybin mushrooms and aiding in setting standards for a burgeoning industry in JamaicaPhytochemistry Letters · 2025-09-30B-302 Psychedelics and Dissociative Anesthetics: Concentrations in Suspected Impaired Driving Investigations, 2024Clinical Chemistry · 2025-09-30Differential effects of psilocybin and lisuride on serotonin and dopamine neuronal activity and behaviorProgress in Neuro-Psychopharmacology and Biological Psychiatry · 2025-09-30Psilocybin during the postpartum period induces long-lasting adverse effects in both mothers and offspringNature Communications · 2025-09-29Psilocybin inhibits formalin-induced nociception through 5-hydroxytryptamine 2A receptor in ratsBehavioural Pharmacology · 2025-09-24Psilocybin-assisted psychotherapy for methamphetamine use disorder: A pilot open-label safety and feasibility studyAddiction · 2025-09-19Dynamic myocardial injury and variable hallucination latency in Psilocybe keralensis poisoning: a molecularly confirmed case series from ChinaClinical Toxicology · 2025-09-14Serotonin 5-HT2C Receptor SignalingAnalysis Reveals Psychedelic Biased AgonismFigshare · 2025-09-12Supporting Meaningful Choices: A Decision Aid for Individuals Facing Existential Distress and Considering Psilocybin-Assisted TherapyHealthcare · 2025-09-11Corrigendum to "Chronic psilocybin administration increases sociability and alters the gut microbiome in male wild-type mice but not in a preclinical model of obsessive-compulsive disorder" [Neuropharmacology 279 (2025) 110648].Unknown journal · 2025-09-11Five-year outcomes of psilocybin-assisted therapy for Major Depressive DisorderJournal of Psychedelic Studies · 2025-09-03PSYCHEDELICS IN PSYCHIATRY - OVERVIEW OF PSILOCYBIN RESEARCHInternational Journal of Innovative Technologies in Social Science · 2025-08-31Psilocybin with psychotherapeutic support for treatment-resistant depression: a pilot clinical trialTherapeutic Advances in Psychopharmacology · 2025-08-31A Phase 2 Single-site, Double-blind, Placebo-controlled, Randomized Clinical Trial With an Open-label Extension Phase to Examine the Safety, Subjective Experiences, Acute Effects, and Suitability of Psilocybin Combined With Psychological Support (Psi-PS) for Military Veterans and First Responders With Co-occurring Alcohol Use Disorder (AUD) and Posttraumatic Stress Disorder (PTSD)ClinicalTrials.gov · 2025-08-27Chronic psilocybin administration increases sociability and alters the gut microbiome in male wild-type mice but not in a preclinical model of obsessive-compulsive disorderNeuropharmacology · 2025-08-20Exploring the Therapeutic Potential of Ketamine and Psilocybin in Comparison to Current Treatment Regimens for Treatment-Resistant Depression, Mood Disorders, and Post-traumatic Stress Disorder in the Pediatric Population: A Narrative Review.Unknown journal · 2025-08-17Toward Standardized Products Containing Biomass of Psilocybe Cubensis FungiJournal of AOAC International · 2025-08-12Psilocybin-assisted psychotherapy for depression and anxiety associated with life threatening illness: A phase 2b randomized controlled trialGeneral Hospital Psychiatry · 2025-08-11Improved mental health outcomes and normalised spontaneous EEG activity in veterans reporting a history of traumatic brain injuries following participation in a psilocybin retreatFrontiers in Psychiatry · 2025-08-05An overview of psilocybin, LSD, MDMA, and ketamine in revitalizing psychedelic-assisted therapy: Insights, limitations and future directions.Unknown journal · 2025-07-24The Medial PrefrontalCortex Modulates Psychedelic-likeEffects of PsilocinFigshare · 2025-07-07The Medial Prefrontal Cortex Modulates Psychedelic-like Effects of PsilocinACS Pharmacology & Translational Science · 2025-07-07Exploring Jordanian Physicians’ and Medical Students’ Perspectives on Ketamine and Psychedelic-Assisted Therapies: An Insight from the Middle EastJournal of Psychoactive Drugs · 2025-07-05Single-dose (10 mg) psilocybin reduces symptoms in adults with obsessive-compulsive disorder: A pharmacological challenge studyComprehensive Psychiatry · 2025-07-01Exploring the Therapeutic Effects of Psychedelics Administered to Military Veterans in Naturalistic Retreat SettingsBrain and Behavior · 2025-06-30Molecular, haemodynamic and functional effects of LSD in the human brainmedRxiv · 2025-06-17The Music for Subanesthetic Infusions of Ketamine randomised clinical trial: ketamine as a psychedelic treatment for highly refractory depressionThe British Journal of Psychiatry · 2025-06-17The molecular mechanisms through which psilocybin prevents suicide: evidence from network pharmacology and molecular docking analysesTranslational Psychiatry · 2025-06-15Enhanced meaning in life following psychedelic use: converging evidence from controlled and naturalistic studiesFrontiers in Psychology · 2025-06-05Understanding the Psychological Effects of Psilocybin and 3,4-Methylenedioxymethamphetamine in a Non-Clinical PopulationmedRxiv · 2025-05-28Patients’ Attitudes Toward Hallucinogenic and Non-Hallucinogenic Psilocybin for Mental Health TreatmentJournal of Psychoactive Drugs · 2025-05-28The Selective Serotonin 5-HT2A Receptor Agonist (S)-3-(2,5-Dimethoxy-4-(trifluoromethyl)phenyl)piperidine (LPH-5) Induces Persistent and Robust Antidepressant-Like Effects in RodentsACS Pharmacology & Translational Science · 2025-05-28Therapeutic emergence of dissociated traumatic memories during psilocybin treatment for anorexia nervosaJournal of Eating Disorders · 2025-05-25Effects of Psilocybin on Religious and Spiritual Attitudes and Behaviors in Clergy from Various Major World ReligionsPsychedelic Medicine · 2025-05-15Aesthetic quality of psychedelic experience is linked to insight and psychological outcomesFrontiers in Psychology · 2025-05-14Non-hallucinogenic psychedelics for mood and anxiety disorders: A systematic review.Unknown journal · 2025-05-07Psilocybin Mitigates Behavioral Despair and Cognitive Impairment in Treatment-resistant Depression Model using Wistar Kyoto RatsResearch Square · 2025-05-05Psychedelic therapy as relational medicine: psychosocial mechanisms in clinical and naturalistic contextsOpen MIND · 2025-05-03Clade III Synthases Add Cyclic and Linear Terpenoids to the Psilocybe MetabolomeChemBioChem · 2025-05-02Psilocybin-gestützte Therapie von Depression, Angst und Suchtstörungen: Neurobiologische Grundlagen und klinische AnwendungNervenheilkunde · 2025-04-30Clinical treatment of cluster headache with the serotonergic indoleamine psychedelics psilocybin and LSD and with ketamine: A case seriesCephalalgia Reports · 2025-04-30From molecules to meaning: unpacking the antidepressant mechanisms of psychedelic drugs.Expert review of clinical pharmacology · 2025-04-30Patterns of Internalizing Problems, Substance Use and Cognitive Flexibility Before and After Naturalistic Psilocybin Use: A Repeated Measures Latent Profile AnalysisInternational Journal of Mental Health and Addiction · 2025-04-23Undergraduate Students' Perceptions and Understanding of Psychedelic-Assisted TherapyExhibit - A Showcase of Scholarship, Creativity and Preservation Provided by Xavier University Library (Xavier University) · 2025-04-22Exploring the perceived usefulness of integration support after naturalistic psychedelic experiences in people concerned about their substance use: A surveyJournal of Psychedelic Studies · 2025-04-21Comprehensive analysis of 42 psilocybin-producing fungal strains reveals metabolite diversity and species-specific clustersScientific Reports · 2025-04-21Rapid and sustained antidepressant effects of vaporized N,N-dimethyltryptamine: a phase 2a clinical trial in treatment-resistant depression.Unknown journal · 2025-04-21Roadmap for Equitable Access and Responsible Use of Psilocybin-Assisted Psychotherapy in Palliative CarePalliative Medicine Reports · 2025-04-16Psilocybin biosynthesis enhancement through gene source optimizationMetabolic Engineering · 2025-04-15Efficacy and safety of psilocybin for the treatment of substance use disorders: A systematic review.Unknown journal · 2025-04-1458. Acute Behavioral Effects of Psilocybin and Its Pharmacokinetics in Nonhuman PrimatesBiological Psychiatry · 2025-04-08166. Dynamic Mediodorsal Thalamus Activity Predicts and Reflects Longitudinal Treatment Outcomes in Psilocybin Therapy for Treatment-Resistant DepressionBiological Psychiatry · 2025-04-08Letter to the editor: Comments on 'Striking long-term beneficial effects of single-dose psilocybin and psychedelic mushroom extract in the SAPAP3 rodent model of OCD-like excessive self-grooming' by Brownstien et al. (2024).Unknown journal · 2025-04-05De Novo Biosynthesis of Antidepressant Psilocybin in Escherichia coliMicrobial Biotechnology · 2025-03-31Psilocybin-Assisted suppoRtive psychoTherapy IN the treatment of prolonged Grief (PARTING) trial: protocol for an open-label pilot trial for cancer-related bereavementBMJ Open · 2025-03-31Pharmacokinetics of Psilocybin: A Systematic Review.Unknown journal · 2025-03-24Structural basis for psilocybin biosynthesisNature Communications · 2025-03-21Synthesis and In Vitro Profiling of Psilocin Derivatives: Improved Stability and Synthetic PropertiesJournal of Medicinal Chemistry · 2025-03-19Lasting effect of psilocybin on sociability can be blocked by DNA methyltransferase inhibitionbioRxiv · 2025-03-10Correction: Clinical Pharmacokinetics of Psilocin After Psilocybin Administration: A Systematic Review and Post-Hoc Analysis.Unknown journal · 2025-02-28Psychedelics and Suicide-Related Outcomes: A Systematic Review.Unknown journal · 2025-02-19Psychedelics and chronic pain: self-reported outcomes on changed substance use patterns and health following naturalistic psychedelic useBritish Journal of Pain · 2025-02-10Psychedelic Information TheoryProceedings of the Annual Conference of CAIS / Actes du congrès annuel de l ACSI · 2025-02-06Dose-dependent changes in global brain activity and functional connectivity following exposure to psilocybin: a BOLD MRI study in awake ratsbioRxiv · 2025-02-05Psilocybin mushroom stewardship: A qualitative inquiry into practices and priorities of “underground” psilocybin mushroom practitionersJournal of Psychedelic Studies · 2025-02-04Psychedelics assisting therapy, or therapy assisting psychedelics? The importance of psychotherapy in psychedelic-assisted therapyFrontiers in Psychology · 2025-02-04Latent Class Analysis of Changes in Substance Use and Depressive Symptoms following Naturalistic Psilocybin Use: Results from a Prospective Longitudinal SurveyDrug and Alcohol Dependence · 2025-01-31Correction: Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'.Unknown journal · 2025-01-29Down the Rabbit Hole: A Large-Scale Survey of Psychedelic Users’ Patterns of Use and Perceived EffectsJournal of Psychoactive Drugs · 2025-01-28From relaxed beliefs under psychedelics (REBUS) to revised beliefs after psychedelics (REBAS)Scientific Reports · 2025-01-28Study Protocol for ‘PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity’Cureus · 2025-01-28Mice lacking the serotonin transporter do not respond to the behavioural effects of psilocybinEuropean Journal of Pharmacology · 2025-01-26Molecular insights into the modulation of the 5 HT2 A receptor by serotonin, psilocin, and the G protein subunit GqαFEBS Letters · 2025-01-25Experiential dimension of psilocybin-assisted therapy training: Necessity or hindrance to wider accessibility?Journal of Psychedelic Studies · 2025-01-20Exploring the Potential of Psychedelics in the Treatment of Headache Disorders: Clinical Considerations and Exploratory Insights.Unknown journal · 2025-01-15Clinical Pharmacokinetics of Psilocin After Psilocybin Administration: A Systematic Review and Post-Hoc Analysis.Unknown journal · 2025-01-14Elucidating the Phase I metabolism of psilocin in vitro.Unknown journal · 2025-01-02Psilocybin rewires specific mouse cortical networks in lasting waysThe Transmitter · 2024-12-31Psilocybin-Assisted Therapy for Trauma-Related Disorders: A Scoping Review of a Depression-Dominated Evidence Base with Implications for Intimate Partner Violence-Related PTSDOpen Science Framework · 2024-12-31Compass Psychological Support Model for COMP360 Psilocybin Treatment of Serious Mental Health ConditionsAmerican Journal of Psychiatry · 2024-12-31Psilocybin alleviates high-glucose and high-lipid-induced skin aging in BJ5Ta fibroblastsBiochemistry and Cell Biology · 2024-12-31Early psilocybin intervention alleviates behavioral despair and cognitive impairment in stressed Wistar ratsProgress in Neuro-Psychopharmacology and Biological Psychiatry · 2024-12-31Music as a collaborating actor: new insights into the nature and role of music in psychedelic-assisted psychotherapy.Frontiers in psychiatry · 2024-12-31Psychedelic Treatment with Psilocybin: Addressing Medical Malpractice Risk and Physicians’ ConcernsThe Journal of Law Medicine & Ethics · 2024-12-31Preferences, Perceptions, and Environmental Considerations of Natural and Synthetic Psychedelic Substances: Findings from the Global Psychedelic SurveyJournal of Psychoactive Drugs · 2024-12-23ALSUntangled #77: Psilocybin.Unknown journal · 2024-12-21Psilocybin increases emotional empathy in patients with major depressionMolecular Psychiatry · 2024-12-17Treatment Expectancies and Psilocybin vs Escitalopram for DepressionJAMA Psychiatry · 2024-12-09Psilocybin-assisted psychotherapy for methamphetamine dependence: a case report involving daily methamphetamine useFrontiers in Psychiatry · 2024-12-05An investigation of acute physiological and psychological moderators of psychedelic-induced personality change among healthy volunteersNeuroscience Applied · 2024-12-01Neurochemical characterization of 5-HT2A R partial agonists with simultaneous PET-MRIJournal of Cerebral Blood Flow & Metabolism · 2024-11-28Neuroimaging of Serotonergic and Psychedelic Agonist Drug Challenges in Non-Human PrimatesProceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition · 2024-11-25Structural insights into tryptamine psychedelics: The role of hydroxyl indole ring site in 5-HT2A receptor activation and psychedelic-like activity.Unknown journal · 2024-11-11